Back
Teleflex Vs. Halozyme Therapeutics Industry Stock Comparison
Sell
31
TFX
Teleflex
Last Price:
201.76
Seasonality Move:
8.66%
Buy
69
HALO
Halozyme Therapeutics
Last Price:
59.82
Seasonality Move:
16.49%
Sell
31
Teleflex (TFX)
is a Sell
Is Teleflex a Buy, Sell or Hold?
- The current Teleflex [TFX] share price is $203.50. The Score for TFX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- TFX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics a Buy, Sell or Hold?
- The current Halozyme Therapeutics [HALO] share price is $58.72. The Score for HALO is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
HALO Stock Price Chart
What is Halozyme Therapeutics's stock price today?
-
The Halozyme Therapeutics share price today is $58.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HALO is experiencing buying pressure, which is a positive indicator for future bullish movement.
TFX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.78 | Sell |
| Relative Strength Index (14 RSI): | 27.57 | Sell |
| Chaikin Money Flow: | -508027 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (220.12 - 243.88) | Sell |
| Bollinger Bands (100): | (215.86 - 243.9) | Sell |
HALO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 64.88 | Buy |
| Chaikin Money Flow: | 1076544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.35 - 56.95) | Buy |
| Bollinger Bands (100): | (51.6 - 59.84) | Buy |
TFX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.63 | Sell |
| 20-day SMA: | 229.97 | Sell |
| 50-day SMA: | 238.18 | Sell |
| 200-day SMA: | 226.16 | Sell |
| 8-day EMA: | 216.85 | Sell |
| 20-day EMA: | 226.91 | Sell |
| 50-day EMA: | 232.46 | Sell |
| 200-day EMA: | 228.59 | Sell |
HALO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.23 | Buy |
| 20-day SMA: | 52.65 | Buy |
| 50-day SMA: | 57.01 | Buy |
| 200-day SMA: | 48 | Buy |
| 8-day EMA: | 54.74 | Buy |
| 20-day EMA: | 53.97 | Buy |
| 50-day EMA: | 55.06 | Buy |
| 200-day EMA: | 50.17 | Buy |
Teleflex Earnings Growth & TFX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $1.32 per share.
Halozyme Therapeutics Earnings Growth & HALO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.66 per share.
Teleflex Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Halozyme Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||